CRL (NYSE: CRL) CIO receives stock grant; shares withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Charles River Laboratories International EVP and Chief Information Officer Mark Mintz received an equity award of 2,534 shares of common stock at a reference price of $180.71 per share. To cover tax obligations, 305 shares on May 30, 2026 and 64 shares on May 31, 2026 were withheld as tax-withholding dispositions, not open-market sales. After these transactions, he directly held 9,546 shares. The related restricted stock units are scheduled to vest annually on May 29 of 2027, 2028, 2029, and 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Mintz Mark
Role
EVP, Chief Information Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 64 | $180.71 | $12K |
| Tax Withholding | Common Stock | 305 | $180.71 | $55K |
| Grant/Award | Common Stock | 2,534 | $180.71 | $458K |
Holdings After Transaction:
Common Stock — 9,546 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Equity grant: 2,534 shares at $180.71
Tax-withholding on May 30, 2026: 305 shares at $180.71
Tax-withholding on May 31, 2026: 64 shares at $180.71
+2 more
5 metrics
Equity grant
2,534 shares at $180.71
Common stock award to EVP & CIO Mark Mintz
Tax-withholding on May 30, 2026
305 shares at $180.71
Common stock withheld to satisfy tax liability
Tax-withholding on May 31, 2026
64 shares at $180.71
Additional common stock withheld for taxes
Post-transaction holdings
9,546 shares
Directly owned common stock after reported transactions
RSU vesting dates
May 29, 2027–May 29, 2030
Unvested restricted stock units vest annually on these dates
Key Terms
tax-withholding disposition, Grant, award, or other acquisition, restricted stock units, Common Stock
4 terms
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
restricted stock units financial
"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transactions did CRL executive Mark Mintz report on this Form 4?
Mark Mintz reported receiving 2,534 shares of Charles River Laboratories common stock as an equity grant at $180.71 per share, with 305 shares and 64 shares withheld on subsequent days to satisfy tax obligations related to that award.
What is the vesting schedule for Mark Mintz’s CRL restricted stock units?
The unvested restricted stock units associated with this award are scheduled to ratably vest annually on May 29 in each of 2027, 2028, 2029, and 2030, according to the footnote disclosure in the Form 4 filing.
What was the reference price used for Mark Mintz’s CRL equity award?
The Form 4 lists a transaction price of $180.71 per share for the 2,534-share equity grant to Mark Mintz. This figure serves as the reference value for the reported award and related tax-withholding dispositions.